Microbes and TNF drive colitis in the absence of innate lymphoid cells
Abstract
Innate lymphoid cells (ILCs) are critical sources of cytokines necessary for intestinal homeostasis in immunocompetent conditions, yet their necessity in innate colitis remains unclear. Using a model of inflammatory bowel disease (IBD) in mice lacking adaptive immunity, we investigated whether ILCs are required for innate colitis. Interleukin-15 receptor alpha-deficient mice lacked intestinal ILC1 and natural killer (NK) cells, but innate colitis in these mice was not diminished. Deletion of IL-2 receptor gamma chain, which ablates all ILCs and NK cells, also did not prevent innate colitis. Antibiotic treatment of mice lacking all ILCs prevented colitis. Similarly, TNF deficiency prevented colitis in the absence of all ILCs, demonstrating that TNF is essential for microbe-driven innate colitis in the absence of ILCs. These findings reveal that ILCs are redundant for innate colitis. Studies of innate colitis in the absence of ILCs may help understand mechanisms underlying IBD and the effectiveness of anti-TNF therapies.
Related
- Multi-omics analysis reveals that sleep deprivation exacerbates intestinal barrier injury via the microbiota-dependent taurodeoxycholic acid/group 3 innate lymphoid/IL-22 axis
- Mother-infant sharing of gut and vaginal microbes at the species and strain level
- Lymphoid gene expression supports neuroprotective microglia function
- Microfluidic Devices for Imaging and Biochemistry Analysis of Microbes Under Mechanical Pressure
- Prehistoric global migration of vanishing gut microbes with humans.
BibTeX
@article{torreshuerta2026microbes,
title = {{Microbes and TNF drive colitis in the absence of innate lymphoid cells}},
author = {Alvaro Torres-Huerta and Arpitha Mysore Rajashekara and Lauren C. Mayer and Katelyn Ruley-Haase and Morgan Hiller and Antonia Boger-May and Theodore Reed and Madeleine Frech and Elsa Bixby and Kyle Elliot and Annie-Cate Schmidt and David L. Boone},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.118000},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03383-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Microbes and TNF drive colitis in the absence of innate lymphoid cells
AU - Alvaro Torres-Huerta
AU - Arpitha Mysore Rajashekara
AU - Lauren C. Mayer
AU - Katelyn Ruley-Haase
AU - Morgan Hiller
AU - Antonia Boger-May
AU - Theodore Reed
AU - Madeleine Frech
AU - Elsa Bixby
AU - Kyle Elliot
AU - Annie-Cate Schmidt
AU - David L. Boone
PY - 2026
DA - 2026/10/27
JO - iScience
DO - 10.1016/j.isci.2026.118000
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03383-3
AB - Innate lymphoid cells (ILCs) are critical sources of cytokines necessary for intestinal homeostasis in immunocompetent conditions, yet their necessity in innate colitis remains unclear. Using a model of inflammatory bowel disease (IBD) in mice lacking adaptive immunity, we investigated whether ILCs are required for innate colitis. Interleukin-15 receptor alpha-deficient mice lacked intestinal ILC1 and natural killer (NK) cells, but innate colitis in these mice was not diminished. Deletion of IL-2 receptor gamma chain, which ablates all ILCs and NK cells, also did not prevent innate colitis. Antibiotic treatment of mice lacking all ILCs prevented colitis. Similarly, TNF deficiency prevented colitis in the absence of all ILCs, demonstrating that TNF is essential for microbe-driven innate colitis in the absence of ILCs. These findings reveal that ILCs are redundant for innate colitis. Studies of innate colitis in the absence of ILCs may help understand mechanisms underlying IBD and the effectiveness of anti-TNF therapies.
SN - 2589-0042
ER -